Clinical Trial Update: Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe Preeclampsia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating extracorporeal removal of sFLT-1 in women with very early severe preeclampsia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Preeclampsia | Phase 2 | Status: TERMINATED